BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8388966)

  • 21. Intraoperative pleural lavage: is it a valid prognostic factor in lung cancer?
    Vicidomini G; Santini M; Fiorello A; Parascandolo V; Calabrò B; Pastore V
    Ann Thorac Surg; 2005 Jan; 79(1):254-7; discussion 254-7. PubMed ID: 15620952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of pleural photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spread.
    Friedberg JS; Mick R; Stevenson JP; Zhu T; Busch TM; Shin D; Smith D; Culligan M; Dimofte A; Glatstein E; Hahn SM
    J Clin Oncol; 2004 Jun; 22(11):2192-201. PubMed ID: 15169808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs).
    Ishii H; Yazawa T; Sato H; Suzuki T; Ikeda M; Hayashi Y; Takanashi Y; Kitamura H
    Lung Cancer; 2004 Sep; 45(3):325-37. PubMed ID: 15301873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrapleural hyperthermic perfusion with chemotherapy increases apoptosis in malignant pleuritis.
    Matsuzaki Y; Edagawa M; Shimizu T; Hara M; Tomita M; Ayabe T; Onitsuka T
    Ann Thorac Surg; 2004 Nov; 78(5):1769-72. PubMed ID: 15511471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of malignant pleural effusion by multimodality treatment including the use of paclitaxel administered by 24-hour intrathoracic infusion for patients with carcinomatous pleuritis.
    Ohta Y; Shimizu Y; Matsumoto I; Watanabe G
    J Exp Clin Cancer Res; 2006 Mar; 25(1):15-9. PubMed ID: 16761613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of pleural effusion caused by lung carcinoma with circular intrapleural hyperthermic perfusion and its mechanism].
    Kang M; Zhou L; Lin P
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1176-9. PubMed ID: 11769704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients].
    Shimizu T; Takahashi N; Terakado M; Sato M; Sugane T; Kisohara A; Akusawa H; Tsujino I; Horie T
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1139-43. PubMed ID: 16121916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limited cardiotoxicity after extensive thoracic surgery and intraoperative hyperthermic intrathoracic chemotherapy with doxorubicin and cisplatin.
    de Bree E; van Ruth S; Schotborgh CE; Baas P; Zoetmulder FA
    Ann Surg Oncol; 2007 Oct; 14(10):3019-26. PubMed ID: 17638057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized phase II trial of OK-432 in patients with malignant pleural effusion due to non-small cell lung cancer.
    Kasahara K; Shibata K; Shintani H; Iwasa K; Sone T; Kimura H; Nobata K; Hirose T; Yoshimi Y; Katayama N; Ishiura Y; Kita T; Nishi K; Nakatsumi Y; Ryoma Y; Fujimura M; Nakao S
    Anticancer Res; 2006; 26(2B):1495-9. PubMed ID: 16619563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intrapleural chemotherapy with cisplatin and adriamycin in lung cancer with carcinomatous pleuritis].
    Fujii M; Kiura K; Okabe K; Toki H
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3203-6. PubMed ID: 3777957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of intraoperative pleural lavage cytology for lung cancer without carcinomatous pleuritis: importance in patients with early stage disease during long-term follow-up.
    Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Takenaka A; Nakayama T; Yoneda G
    Eur J Cardiothorac Surg; 2009 Feb; 35(2):337-42. PubMed ID: 19041255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of intraoperative intrapleural cisplatin chemotherapy of various osmolarities in cases of esophageal cancer.
    Katano K; Tsujitani S; Maeta M; Fukuda K; Oka S; Hisamitsu K; Ikeguchi M; Kaibara N
    Oncol Rep; 2001; 8(3):605-9. PubMed ID: 11295088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment.
    Opitz I; Lardinois D; Arni S; Hillinger S; Vogt P; Odermatt B; Rousson V; Weder W
    Eur J Cardiothorac Surg; 2007 May; 31(5):773-8. PubMed ID: 17350855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pleural perfusion thermo-chemotherapy under VATS: a new less invasive modality for advanced lung cancer with pleural spread.
    Shigemura N; Akashi A; Nakagiri T; Hazama K; Ohta M; Matsuda H
    Ann Thorac Surg; 2004 Mar; 77(3):1016-21; discussion 1021-2. PubMed ID: 14992917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical outcome of lung cancer patients with carcinomatous pleuritis.
    Pagan V; Fontana P; Zaccaria A; Lo Giudice F; Oniga F
    Chir Ital; 2005; 57(6):703-8. PubMed ID: 16400764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimodality treatment including parietal pleurectomy as a possible therapeutic procedure for malignant pleural effusion.
    Ohta Y; Oda M; Shimizu J; Watanabe G
    Surg Technol Int; 2007; 16():184-9. PubMed ID: 17429787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Exploratory thoracotomy: causes of inoperability of non-small-cell lung cancer].
    Akonov AL; Levashev IuN
    Vopr Onkol; 2002; 48(1):78-82. PubMed ID: 12101574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re: Modified intrapleural cisplatin treatment for lung cancer with positive pleural lavage cytology or malignant effusion, by Muraoka M, Oka T, Akamine S, et al.
    Johnstone DW
    J Surg Oncol; 2006 Mar; 93(4):255-6. PubMed ID: 16496362
    [No Abstract]   [Full Text] [Related]  

  • 39. Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer.
    Grunenwald DH; André F; Le Péchoux C; Girard P; Lamer C; Laplanche A; Tarayre M; Arriagada R; Le Chevalier T
    J Thorac Cardiovasc Surg; 2001 Oct; 122(4):796-802. PubMed ID: 11581616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.